MX2010002910A - Infectious disease testing of menstrual fluid, endometrial /menstrual cells, amniotic fluid, umbilical cord blood or other samples. - Google Patents

Infectious disease testing of menstrual fluid, endometrial /menstrual cells, amniotic fluid, umbilical cord blood or other samples.

Info

Publication number
MX2010002910A
MX2010002910A MX2010002910A MX2010002910A MX2010002910A MX 2010002910 A MX2010002910 A MX 2010002910A MX 2010002910 A MX2010002910 A MX 2010002910A MX 2010002910 A MX2010002910 A MX 2010002910A MX 2010002910 A MX2010002910 A MX 2010002910A
Authority
MX
Mexico
Prior art keywords
fluid
menstrual
endometrial
infectious disease
umbilical cord
Prior art date
Application number
MX2010002910A
Other languages
Spanish (es)
Inventor
Julie G Allickson
Mercedes A Walton
Original Assignee
Cryo Cell Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cryo Cell Int filed Critical Cryo Cell Int
Publication of MX2010002910A publication Critical patent/MX2010002910A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Methods are provided for obtaining and testing or analyzing a non-venous and non-arterial puncture human fluid or cell sample or human body fluid or cell sample to detect the presence of at least one infectious disease. The sample may be menstrual fluid, endometrial menstrual cells, umbilical cord blood, or amniotic fluid. Confirmatory testing of a corresponding arterial or venous blood sample for comparison to the test results for the non-venous and non-arterial human fluid or cell sample may be performed. The testing may comprise a screening test or a confirmatory test.
MX2010002910A 2007-09-14 2008-09-15 Infectious disease testing of menstrual fluid, endometrial /menstrual cells, amniotic fluid, umbilical cord blood or other samples. MX2010002910A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99374807P 2007-09-14 2007-09-14
US19160108P 2008-09-09 2008-09-09
PCT/US2008/010751 WO2009035706A1 (en) 2007-09-14 2008-09-15 Infectious disease testing of menstrual fluid, endometrial /menstrual cells, amniotic fluid, umbilical cord blood or other samples

Publications (1)

Publication Number Publication Date
MX2010002910A true MX2010002910A (en) 2010-05-24

Family

ID=40452371

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010002910A MX2010002910A (en) 2007-09-14 2008-09-15 Infectious disease testing of menstrual fluid, endometrial /menstrual cells, amniotic fluid, umbilical cord blood or other samples.

Country Status (15)

Country Link
EP (1) EP2200620A4 (en)
JP (1) JP2010539479A (en)
KR (1) KR20100063089A (en)
CN (1) CN101854942A (en)
AR (1) AR068449A1 (en)
AU (1) AU2008299884A1 (en)
BR (1) BRPI0817333A2 (en)
CA (1) CA2699491A1 (en)
CL (1) CL2008002749A1 (en)
CR (1) CR11315A (en)
EC (1) ECSP10010048A (en)
MX (1) MX2010002910A (en)
NI (1) NI201000037A (en)
TW (1) TW200918020A (en)
WO (1) WO2009035706A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015018035A (en) * 2013-07-03 2016-07-06 Coyne Ip Holdings Llc Methods for predicting responses to chemical or biologic substances.
AU2015302059B2 (en) 2014-08-12 2020-02-06 Nextgen Jane, Inc. System and method for monitoring health based on collected bodily fluid
WO2017180909A1 (en) 2016-04-13 2017-10-19 Nextgen Jane, Inc. Sample collection and preservation devices, systems and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725481A (en) * 1996-05-17 1998-03-10 A. Fem Medical Corporation Method and apparatus for collecting vaginal fluid and exfoliated vaginal cells for diagnostic purposes
US7638093B2 (en) * 2004-01-28 2009-12-29 Dnt Scientific Research, Llc Interrupted flow rapid confirmatory immunological testing device and method
MX2009009414A (en) * 2007-03-01 2009-11-02 Cryo Cell Int Procurement, isolation and cryopreservation of endometrial/menstrual cells.

Also Published As

Publication number Publication date
CN101854942A (en) 2010-10-06
NI201000037A (en) 2011-06-21
AR068449A1 (en) 2009-11-18
EP2200620A4 (en) 2010-10-27
CL2008002749A1 (en) 2010-05-07
AU2008299884A1 (en) 2009-03-19
EP2200620A1 (en) 2010-06-30
TW200918020A (en) 2009-05-01
KR20100063089A (en) 2010-06-10
BRPI0817333A2 (en) 2017-06-13
JP2010539479A (en) 2010-12-16
CA2699491A1 (en) 2009-03-19
WO2009035706A1 (en) 2009-03-19
CR11315A (en) 2010-08-13
ECSP10010048A (en) 2010-06-29

Similar Documents

Publication Publication Date Title
WO2006091412A3 (en) Adamts-7 as a biomarker for cancers of epithelial origin
WO2007147076A3 (en) Methods for the diagnosis of fetal abnormalities
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
GB201300533D0 (en) Methods of monitoring conditions by sequence analysis
HRP20130618T1 (en) Methods of using mirna for detection of in vivo cell death
WO2006024466A3 (en) Test device for the in vitro diagnosis of multi-analyte tests and the use thereof
WO2014036495A3 (en) Diagnostic assays and kits for detection of folate receptor 1
BR112015026222A2 (en) biological fluid sample collection device
ATE474228T1 (en) REAGENT FOR HEMOGLOBINA DEGRADATION
EP4273548A3 (en) Serologic assay for silent brain ischemia
MX2010002910A (en) Infectious disease testing of menstrual fluid, endometrial /menstrual cells, amniotic fluid, umbilical cord blood or other samples.
ATE499877T1 (en) DIAGNOSTIC DISPOSABLE PART
BR112016002709A2 (en) keratins as biomarkers for cervical cancer and survival
WO2012054824A3 (en) Prognostic biomarkers in patients with ovarian cancer
ES2530357T3 (en) Method to detect a plasmodium infection
WO2010133881A3 (en) Tissue analysis
MX2010002009A (en) Male reproductive health panel and uses thereof.
EP1988164A4 (en) Method of testing sensitivity of solid cancer against tyrosine kinase inhibitor and test kit therefor
EP1773762A4 (en) Methods and compounds for detection of medical disorders
ATE545027T1 (en) SAMPLE COLLECTION PROCEDURES
EG24879A (en) Test element and method for testing blood
WO2012146940A3 (en) Gadd45beta as an expression marker useful for the diagnosis, prognosis and theranostics of cancer
이미화 The Elevation Factors Associated with Increased Blood Glucose in Gravida
PL422611A1 (en) Method for detecting kidney damage, occurring in diabetics
RU2010118699A (en) DIAGNOSTIC METHOD FOR DETECTING CANCER CELLS

Legal Events

Date Code Title Description
FA Abandonment or withdrawal